- Tel：0086 29 89196049
- Mobi：+86 17342318735 +86 18089264518
- Add：Constellation 11107 Oak
- Technology 5th Road, Xi'an
Chinese plant extract market development trend
Although 80% of China's plant extracts are exported, but did not master the international discourse. Almost all the extracts of well-known brands have been occupied by Japan and the United States, and our raw materials and plant extracts are still in early form of processed products export-oriented. In addition, to avoid "bad money good money by" dilemma, and to adapt to international standards, the development of plant extracts of national standards is imperative.
The first half of this year, exports of plant extracts has reached 310 million U.S. dollars, up 17.5 percent, an increase of Chinese medicine is the only product of its growth to the overall rise in Chinese exports.
Exports in the first half of plant extracts has been ranked first in exports of Chinese goods, and gradually increase the proportion, Chinese exports accounted for 47.2% of total merchandise exports.
Luo Yang analysis, a large amount of plant extracts is mainly export of some products as food additives. Especially food colorings, demand increased substantially during the first half of this year, led to the export of whole plant extracts. Such as Mexico and some other countries, traditional eating habits are more sensitive to food color, hence the demand for certain food colorings also larger in the first half of Mexican exports pepper pigments were recorded.
"All along, the international demand for plant extracts are relatively stable, relatively strong growth is expected in the second half of the export of plant extracts still maintained steadily trend. And this year the export tax rebate adjustment in some plant extracts have been recovery from 13% to 15%, export increased confidence on China's export enterprises will play a larger role in promoting. "Luo Yang said.
According to Zhejiang CONBA Kuang Pharmaceutical Co., Ltd. Chief Consultant wish good analysis estimates that the export of plant extracts as a main staple varieties of Ginkgo biloba extract, the international market has been as high as 70 billion U.S. dollars, Canadian pharmacies and hospitals in the domestic market has far exceeded the $ 3.0 billion plant extracts market has become a huge number of pharmaceutical companies competing for the cake.
Plant extracts export surge has also touched a sensitive nerve in many enterprises. Shanghai Medicines and Health Products Import and Export Corporation, general manager of Jiangzhen Wei told reporters that the United States and Europe because of the increased demand for plant extracts, companies will adjust the export structure, in the second half ready to increase the plant extract products exports.
Although the plant extracts in the financial crisis continues to show resilience under the influence of the trend, but its deep-seated problems within the industry has become a plant extract further into the international market shackles.
"At present, China's business enterprises plant extracts about 2000, but truly international competitiveness of enterprises does not have much, industry concentration is poor, the international competitiveness of small, although 80% of the plant to China's products are for export, but did did not master the international discourse. "Luo Yang said so.
China plant extract from the current situation of the industry, now extract a single product without their own brands and patents, the lack of key technologies and market advantages; species-rich plant resources are not rational and effective use and development. Poor new product development, brand awareness is weak and has become the implant industry to a common problem.
As a result, plant extracts a new product development and brand protection much industry attention. According to reports, the Chinese Medicines and Health Products Import and Export Chamber of Commerce organized the "Chinese plant extracts to enhance the international competitiveness of the industry forum" will be held in September, will explore the international market supplement hot plant components and innovation of Chinese enterprises and brand protection issues.
Currently enterprises to plant more to imitate, but few truly unique product, the product homogeneous competition. And lower the access threshold for plant extracts, once popular in the international class of goods, companies are likely to follow the trend of indiscriminate, low-quality low-cost cut-throat competition seriously.
A general review of the international market, almost all of the extracts of well-known brands have been occupied by Japan and the United States, and plant extracts in China is still in the form of raw materials and primary processed products export-oriented.
Study the practical reasons, said Luo Yang, mainly plant extracts standards. Plant extracts on the relevant standards, is still an industry standard, the lack of national standards.
Because standards are not uniform plant extracts, not perfect, the current industry standard is only a plant extract for the finished product, while the plant extracts contained in the finished composition, but not required, resulting in some bad business loophole, Add low-quality illegal material.
To Ginkgo biloba extract, for example, according to Zhu Kuang Shan said the current market price is high and low acid acid is much higher, and some enterprises in order to benefit, in violation of rules to add high-acid extract, ginkgo extract makes the price several times, resulting in the quality to compete with low-grade Ginkgo biloba extract ginkgo extract products embarrassment.
Recently, the U.S. has also proposed that the export of plant extracts products, raw materials must be certified by the U.S. cGMP. I wish Peter good that the surface, which China's export of plant extracts negative, but in fact it is conducive to China to implant industry norms.
In Guangdong, the introduction of differential pricing of medicines, allowing the implementation of differential pricing of certain foreign products. I wish Peter good that this raw material with different drugs have a great relationship.
In order to meet international standards, has been the first to take the initiative CONBA improve the standard Ginkgo biloba extract. The revised draft of the 2010 edition of Pharmacopoeia, also adopted CONBA provide the advice of the Ginkgo biloba extract in the ginkgolide content from 15% to scientifically adjusted to 12%.
The first half of this year, exports of plant extracts has reached 310 million U.S. dollars, up 17.5 percent, an increase of Chinese medicine is the only product of its growth to the overall rise in Chinese exports.
Exports in the first half of plant extracts has been ranked first in exports of Chinese goods, and gradually increase the proportion, Chinese exports accounted for 47.2% of total merchandise exports.
Luo Yang analysis, a large amount of plant extracts is mainly export of some products as food additives. Especially food colorings, demand increased substantially during the first half of this year, led to the export of whole plant extracts. Such as Mexico and some other countries, traditional eating habits are more sensitive to food color, hence the demand for certain food colorings also larger in the first half of Mexican exports pepper pigments were recorded.
"All along, the international demand for plant extracts are relatively stable, relatively strong growth is expected in the second half of the export of plant extracts still maintained steadily trend. And this year the export tax rebate adjustment in some plant extracts have been recovery from 13% to 15%, export increased confidence on China's export enterprises will play a larger role in promoting. "Luo Yang said.
According to Zhejiang CONBA Kuang Pharmaceutical Co., Ltd. Chief Consultant wish good analysis estimates that the export of plant extracts as a main staple varieties of Ginkgo biloba extract, the international market has been as high as 70 billion U.S. dollars, Canadian pharmacies and hospitals in the domestic market has far exceeded the $ 3.0 billion plant extracts market has become a huge number of pharmaceutical companies competing for the cake.
Plant extracts export surge has also touched a sensitive nerve in many enterprises. Shanghai Medicines and Health Products Import and Export Corporation, general manager of Jiangzhen Wei told reporters that the United States and Europe because of the increased demand for plant extracts, companies will adjust the export structure, in the second half ready to increase the plant extract products exports.
Although the plant extracts in the financial crisis continues to show resilience under the influence of the trend, but its deep-seated problems within the industry has become a plant extract further into the international market shackles.
"At present, China's business enterprises plant extracts about 2000, but truly international competitiveness of enterprises does not have much, industry concentration is poor, the international competitiveness of small, although 80% of the plant to China's products are for export, but did did not master the international discourse. "Luo Yang said so.
China plant extract from the current situation of the industry, now extract a single product without their own brands and patents, the lack of key technologies and market advantages; species-rich plant resources are not rational and effective use and development. Poor new product development, brand awareness is weak and has become the implant industry to a common problem.
As a result, plant extracts a new product development and brand protection much industry attention. According to reports, the Chinese Medicines and Health Products Import and Export Chamber of Commerce organized the "Chinese plant extracts to enhance the international competitiveness of the industry forum" will be held in September, will explore the international market supplement hot plant components and innovation of Chinese enterprises and brand protection issues.
Currently enterprises to plant more to imitate, but few truly unique product, the product homogeneous competition. And lower the access threshold for plant extracts, once popular in the international class of goods, companies are likely to follow the trend of indiscriminate, low-quality low-cost cut-throat competition seriously.
A general review of the international market, almost all of the extracts of well-known brands have been occupied by Japan and the United States, and plant extracts in China is still in the form of raw materials and primary processed products export-oriented.
Study the practical reasons, said Luo Yang, mainly plant extracts standards. Plant extracts on the relevant standards, is still an industry standard, the lack of national standards.
Because standards are not uniform plant extracts, not perfect, the current industry standard is only a plant extract for the finished product, while the plant extracts contained in the finished composition, but not required, resulting in some bad business loophole, Add low-quality illegal material.
To Ginkgo biloba extract, for example, according to Zhu Kuang Shan said the current market price is high and low acid acid is much higher, and some enterprises in order to benefit, in violation of rules to add high-acid extract, ginkgo extract makes the price several times, resulting in the quality to compete with low-grade Ginkgo biloba extract ginkgo extract products embarrassment.
Recently, the U.S. has also proposed that the export of plant extracts products, raw materials must be certified by the U.S. cGMP. I wish Peter good that the surface, which China's export of plant extracts negative, but in fact it is conducive to China to implant industry norms.
In Guangdong, the introduction of differential pricing of medicines, allowing the implementation of differential pricing of certain foreign products. I wish Peter good that this raw material with different drugs have a great relationship.
In order to meet international standards, has been the first to take the initiative CONBA improve the standard Ginkgo biloba extract. The revised draft of the 2010 edition of Pharmacopoeia, also adopted CONBA provide the advice of the Ginkgo biloba extract in the ginkgolide content from 15% to scientifically adjusted to 12%.
